Pancreatic Cancer Research

ResearcherAscension Providence HospitalNo recent work listed

Dulabh Kaur Monga

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5021211614. Sources: OpenAlex.

Their work

Papers
10 (first author 0, last author 4)
Trials
0
Grants
0
Labs led
1
Collaborators
23
Papers, trials and grants by year

2013: 1 paper · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: 4 papers · 2020: 1 paper · 2021: 1 paper · 2022: 1 paper · 2023: 2 papers

Papers 10

  1. Prophylactic Anticoagulation in Patients With Pancreatic Adenocarcinoma: A Single Tertiary Care Center Retrospective QI Project. Last author DOI 10.21873/anticanres.16142↗
  2. Targeted Therapy for BRAF V600E Positive Pancreatic Adenocarcinoma: Two Case Reports. Last author DOI 10.21873/cgp.20391↗
  3. A randomized, phase II trial of oral azacitidine (CC-486) in patients with resected pancreatic adenocarcinoma at high risk for recurrence. Co-author DOI 10.1186/s13148-022-01367-8↗
  4. An Internal Review of Rates of Palliative Medicine Referral for Patients With Advanced Pancreatic Cancer. Last author DOI 10.7759/cureus.19670↗
  5. Survival Trends for Resectable Pancreatic Cancer Using a Multidisciplinary Conference: the Impact of Post-operative Chemotherapy. Co-author DOI 10.1007/s12029-019-00303-z↗
  6. Performance of a Multidisciplinary Pancreatic Cancer Conference in Predicting and Managing Resectable Pancreatic Cancer. Co-author DOI 10.1097/mpa.0000000000001209↗
  7. Time to Adjuvant Systemic Therapy Following Pancreatic Cancer Resection and Effect on Outcome. Co-author DOI 10.1097/mpa.0000000000001373↗
  8. Long-term outcomes by response to neoadjuvant chemotherapy or chemoradiation in patients with resected pancreatic adenocarcinoma. Co-author DOI 10.21037/jgo.2019.07.02↗
  9. Incidence and risk factors for post-operative mortality, hospitalization, and readmission rates following pancreatic cancer resection. Co-author DOI 10.21037/jgo.2019.09.01↗
  10. An extremely rare case of pancreatic cancer presenting with leptomeningeal carcinomatosis and synchronous intraparenchymal brain metastasis. Last author PMID 23936550↗

Closest collaborators

The 23 strongest of 23 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Suzanne Schiffman · 4 shared papers, 2019–2020 · strength 0.34
  2. Shyam J Thakkar · 4 shared papers, 2019–2020 · strength 0.34
  3. Alexander V. Kirichenko · 4 shared papers, 2019–2020 · strength 0.34
  4. Rodney E. Wegner · 3 shared papers, 2019 · strength 0.28
  5. Shivani Shah · 1 shared paper, 2023 · strength 0.26
  6. Shivani S. Shah · 1 shared paper, 2023 · strength 0.26
  7. Vivek Verma · 2 shared papers, 2019 · strength 0.19
  8. Aslam Syed · 2 shared papers, 2019–2020 · strength 0.16
  9. Deanna L Huffman · 1 shared paper, 2021 · strength 0.14
  10. Peter James O'Dwyer · 1 shared paper, 2022 · strength 0.13
  11. Marina Baretti · 1 shared paper, 2022 · strength 0.13
  12. Thatcher Ross Heumann · 1 shared paper, 2022 · strength 0.13
  13. Nilofer Saba Azad · 1 shared paper, 2022 · strength 0.13
  14. Nita Ahuja · 1 shared paper, 2022 · strength 0.13
  15. Colin D. Weekes · 1 shared paper, 2022 · strength 0.13
  16. Kim A. Reiss · 1 shared paper, 2022 · strength 0.13
  17. Ahmed Khattab · 1 shared paper, 2019 · strength 0.10
  18. Ethan Bernard Ludmir · 1 shared paper, 2019 · strength 0.10
  19. Gursimran Singh Kochhar · 1 shared paper, 2020 · strength 0.09
  20. Richard J. White · 1 shared paper, 2019 · strength 0.09
  21. Bharat Rao · 1 shared paper, 2019 · strength 0.07
  22. Amy Tang · 1 shared paper, 2019 · strength 0.07
  23. Rohit Rao · 1 shared paper, 2013 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.